Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;1(1):53-59.
doi: 10.1007/s11468-006-9006-7. Epub 2006 Mar 1.

Microwave-Accelerated and Metal-Enhanced Fluorescence Myoglobin Detection on Silvered Surfaces: Potential Application to Myocardial Infarction Diagnosis

Microwave-Accelerated and Metal-Enhanced Fluorescence Myoglobin Detection on Silvered Surfaces: Potential Application to Myocardial Infarction Diagnosis

Kadir Aslan et al. Plasmonics. 2006 Mar.

Abstract

In this short paper, we describe a novel approach to both significantly accelerate and optically amplify fluorescence-based immunoassays. Our approach utilizes metal-enhanced fluorescence (MEF) to intrinsically optically amplify fluorescence signatures, which, when combined with the use of low-power microwaves to kinetically accelerate assays, provides for both ultrafast and ultrabright immunoassays. Surprisingly, the use of low-power microwaves and silver nanostructures provides for localized heating, concentrating the effect to the particles themselves as compared to the generic heating of the high dielectric assay fluid. We have subsequently applied our microwave-accelerated MEF approach to the detection of myoglobin, where its rapid quantification is paramount for the clinical assessment of an acute myocardial infarction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Microwave-accelerated metal-enhanced fluorescence myoglobin immunoassay.
Figure 2
Figure 2
Total-internal reflection fluorescence geometry for myoglobin assessment.
Figure 3
Figure 3
Absorption spectrum of silver-island films (SiFs) both before and after exposure to low-power microwaves.
Figure 4
Figure 4
Emission spectrum of Alexa 647 on both SiFs and glass after 30-min incubation (top) and normalized to the fluorescence emission on glass (bottom). The spectra are the mean of five measurements on the respective surfaces.
Figure 5
Figure 5
Emission spectrum of Alexa 647 on both SiFs and glass after 20-s low-power microwave heating (top) and normalized to the fluorescence emission on glass (bottom). The spectra are the mean of five measurements on the respective surfaces.
Figure 6
Figure 6
Control experiments: emission spectrum of Alexa 647 on both SiFs and glass after 30-s incubation at room temperature (with myoglobin; top), after 30-min incubation at room temperature (no myoglobin; middle), and after 30-s low-power microwave heating (no myoglobin; bottom).
Figure 7
Figure 7
Emission intensity of Alexa 647 on both SiFs and glass after cumulative low-power microwave heating. λex = 650 nm.

Similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9342013', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9342013/'}]}
    2. Ellenius J, Groth T, Lindahl B, Wallentin L (1997) Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis. Clin Chem 43:1919–1925 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11294799', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11294799/'}]}
    2. Newby LK, Storrow AB, Gibler WB, Garvey JL, Tucker JF, Kaplan AL, Schreiber DH, Tuttle RH, McNulty SE, Ohman EM (2001) Bedside multimarker testing for risk stratification in chest pain units—the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 103:1832–1837 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10451245', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10451245/'}]}
    2. Storrow AB, Gibler WB (1999) The role of cardiac markersin the emergency department. Clin Chim Acta 284:187–196 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10475079', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10475079/'}]}
    2. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, WuAH (1999) Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 37:687–693 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7785657', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7785657/'}]}
    2. Woo J, Lacbawan FL, Sunheimer R, LeFever D, McCabe JB (1995) Is myoglobin useful in the diagnosis ofacute myocardial-infarction in the emergency department setting. Am J Clin Pathol 103:725–729 - PubMed

LinkOut - more resources